A carregar...
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma
SIMPLE SUMMARY: In the last decade, proteasome inhibitors (PIs) have become a standard for the treatment of multiple myeloma (MM). As a consequence of the pleiotropic effects of PIs on various signaling pathways, synergistic or additive activities with other anti-myeloma therapies have been identifi...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000754/ https://ncbi.nlm.nih.gov/pubmed/33799793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061235 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|